1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,200 | 1,256 | 20:28 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12.24 | Nanoform Finland Plc - Manager's Transactions - Peter Hänninen | 3 | Cision News | ||
| 18.12.24 | Nanoform Finland Plc - Manager's Transactions - Edward Hæggström | 3 | Cision News | ||
| NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
| 18.12.24 | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 1 | Cision News | ||
| 18.12.24 | The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees | 2 | Cision News | ||
| 18.12.24 | Nanoform Finland Plc - Managers' transactions - Antonio Da Silva | 4 | Cision News | ||
| 19.11.24 | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 2 | Cision News | ||
| 19.11.24 | Nanoform Finland Plc - Manager's Transactions - Peter Hänninen | 2 | Cision News | ||
| 18.11.24 | Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed | 519 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
November 18, 2024
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform Q3 2024 report: Record number of new projects signed
A record number of new... ► Artikel lesen | |
| 04.11.24 | Invitation to Nanoform's Q3 2024 Report Presentation | 2 | Cision News | ||
| 25.10.24 | Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release | 2 | Cision News | ||
| 22.10.24 | Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 | 1 | Cision News | ||
| 05.09.24 | Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants | 5 | Cision News | ||
| 29.08.24 | Nanoform Q2 report: All business targets for 2024 on track | 1 | Cision News | ||
| 16.08.24 | Invitation to Nanoform's Q2 2024 Report Presentation | 1 | Cision News | ||
| 15.08.24 | Nanoform Collaborates with Takeda on Plasma-derived Therapy Development | 14 | Contract Pharma | ||
| 15.08.24 | NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT | 815 | PR Newswire | HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development... ► Artikel lesen | |
| 30.05.24 | Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned | 585 | PR Newswire | HELSINKI, May 30, 2024 /PRNewswire/ -- Manufacturing of GMP material in Project Nanoenzalutamide commenced. EU/US pivotal studies are planned to start in 4Q24, with the read-out in 1Q25.... ► Artikel lesen | |
| 09.04.24 | Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer | 842 | PR Newswire | Nanoform Finland Plc
April 9, 2024
09.00 EEST / 08.00 CEST
HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company... ► Artikel lesen | |
| 15.02.24 | Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines | 655 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
| 26.01.24 | Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide | 720 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 54,90 | +0,55 % | So startet der DAX in die neue Woche - Aktien von Siemens Energy und Formycon im Fokus | So startet der DAX in die neue Handelswoche. Dürfen sich Anleger bald über ein neues Rekordhoch freuen? Außerdem im Fokus der Börse: Die Aktien von Siemens Energy und Formycon. Nur knapp unter einem... ► Artikel lesen | |
| KOPIN | 2,018 | +12,11 % | Pre-market Movers: Diginex, Vince Holding, CTRL Group, Vertical Aerospace, Kopin | REDWOOD SHORES (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).In the Green Diginex Limited (DGNX) is up over 107% at... ► Artikel lesen | |
| GAUZY | 12,280 | -3,69 % | GAUZY LTD: Gauzy's and Journeo's Strategic Partnership on Track to Enhance Road Safety on London's Fleet of 8,500 Buses With Smart-Vision Advanced Driver Assistance System (ADAS) | ||
| VEECO INSTRUMENTS | 24,600 | -3,15 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
| ONTO INNOVATION | 202,00 | -3,81 % | Onto Innovation CEO verkauft Aktien im Wert von 7,67 Millionen US-Dollar | ||
| DOTZ NANO | 0,053 | -4,55 % | DOTZ NANO LIMITED: Notification regarding unquoted securities - DTZ | ||
| NVE | 69,00 | 0,00 % | NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend | EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter ended December 31, 2024.
Total revenue for the third quarter of fiscal... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,110 | +7,35 % | FendX Technologies Inc.: FendX Announces RSU Grant | Oakville, Ontario--(Newsfile Corp. - December 19, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
| NANOVIRICIDES | 1,120 | +3,70 % | NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 | SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus... ► Artikel lesen | |
| ZENTEK | 1,040 | -2,80 % | Zentek Provides Update on ZenGUARD Enhanced Air Filters for the Canadian Market | GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide... ► Artikel lesen | |
| ACACIA RESEARCH | 4,140 | -0,48 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,492 | +7,42 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LEHNER INVESTMENTS | 0,024 | 0,00 % | EQS-News: LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand
25.11.2024 / 16:15 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 1,260 | 0,00 % | NanoFocus passt Prognose für 2024 an | Die NanoFocus AG hat heute beschlossen, die Prognose für das laufende Jahr anzupassen. Aufgrund von gegenwärtig absehbar deutlich niedrigeren Umsätzen in den Bereichen Semiconductor Asia und Standard/Labor... ► Artikel lesen | |
| RIBER | 3,700 | -0,80 % | RIBER secures a repeat order for an MBE 412 cluster system in the USA | RIBER secures a repeat order for an MBE 412 cluster system in the USA Bezons (France), January 9, 2025 - 8:00am (CET) - RIBER, the global leader for Molecular Beam Epitaxy (MBE) equipment serving... ► Artikel lesen |
Das Unternehmen NANOFORM FINLAND OYJ kann der Branche Nanotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 1,228 Euro und damit +0,16 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOFORM FINLAND OYJ finden Sie auf Wallstreet Online.
